Drug Profile
Research programme: rheumatoid arthritis therapy - elbion NV
Alternative Names: elbion NV-RALatest Information Update: 20 Jul 2010
Price :
$50
*
At a glance
- Originator elbion NV
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 20 Jul 2010 Discontinued - Preclinical for Rheumatoid arthritis in Belgium (unspecified route)
- 14 Nov 2008 Biotie Therapies acquires elbion NV
- 05 Dec 2006 4AZA Bioscience has merged with elbion to form elbion NV